Cocrystal Pharma, Inc. (COCP) vs Dyadic International, Inc. (DYAI)

A side-by-side comparison of Cocrystal Pharma, Inc. and Dyadic International, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — COCP vs DYAI

growth of $100 · dividends reinvested · last 10y
COCP -99.4% (-39.6%/yr)DYAI -70.5% (-11.5%/yr)DYAI compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $10020182020202220242026$1$29
COCP DYAI

COCP vs DYAI: by the numbers

  • •DYAI is the larger company ($16M vs $15M market cap).
  • •Both run net losses; DYAI's is the smaller (-219.50% vs -3011.52% net margin).
  • •COCP grew revenue faster over the past five years (91.55% vs -5.11% CAGR).

Metrics side by side

Valuation

MetricCOCPDYAI
P/S ratio46.174.72
P/B ratio14.59N/A

Profitability

MetricCOCPDYAI
Gross margin0.00%-88.25%
Operating margin0.00%-579.88%
Net margin-3011.52%-219.50%
ROE-951.92%N/A
ROIC-497.29%-279.48%

Growth (annualized)

MetricCOCPDYAI
Revenue CAGR (5Y)91.55%-5.11%
Total return CAGR (5Y)-37.50%-38.53%

Frequently asked

Which has grown faster, COCP or DYAI?
Over the past five years, COCP grew revenue faster — COCP at a 91.55% CAGR versus DYAI at -5.11%.
How have COCP and DYAI total returns compared?
Over the past 10 years, COCP delivered -39.76% and DYAI delivered -11.56% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.